These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8157560)

  • 1. P-nitrophenylglycerol in susceptibility media alters the MICs of antimicrobial agents for Pseudomonas aeruginosa.
    Bone FJ; Mundle R; Dale BA; MacRae KS; Wallace W
    J Antimicrob Chemother; 1994 Jan; 33(1):179-80; author reply 180-1. PubMed ID: 8157560
    [No Abstract]   [Full Text] [Related]  

  • 2. P-nitrophenylglycerol in susceptibility media alters the MICs of antimicrobial agents for Pseudomonas aeruginosa.
    Franklin JR; Hobson JA
    J Antimicrob Chemother; 1994 Jan; 33(1):179; author reply 180-1. PubMed ID: 8157559
    [No Abstract]   [Full Text] [Related]  

  • 3. P-nitrophenylglycerol in susceptibility testing media alters the MICs of antimicrobials for Pseudomonas aeruginosa.
    Ward PB; Palladino S; Looker JC; Feddema P
    J Antimicrob Chemother; 1993 Apr; 31(4):489-96. PubMed ID: 8514647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-nitrophenylglycerol in susceptibility testing media alters the MICs of antimicrobials for aerobic gram-negative bacilli.
    Ward PB; Palladino S; Looker JC
    J Antimicrob Chemother; 1993 May; 31(5):803-5. PubMed ID: 8335510
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial susceptibility of mucoid Pseudomonas aeruginosa and their spontaneously occurring non-mucoid derivatives.
    Markowitz SM; Macrina FL; Phibbs PV
    J Antimicrob Chemother; 1980 Mar; 6(2):251-60. PubMed ID: 6769896
    [No Abstract]   [Full Text] [Related]  

  • 6. MICs of rifampicin and chloramphenicol for mucoid Pseudomonas aeruginosa strains are lower when human lactoferrin is present.
    Fowler CE; Soothill JS; Oakes L
    J Antimicrob Chemother; 1997 Dec; 40(6):877-9. PubMed ID: 9462441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of fosfomycin against multidrug-resistant Pseudomonas aeruginosa in vitro.
    Kobayashi Y; Sumitani Y; Sugita K; Aikawa N
    Int J Antimicrob Agents; 2007 Dec; 30(6):563-4. PubMed ID: 17900870
    [No Abstract]   [Full Text] [Related]  

  • 8. [The sensitivity of Pseudomonas aeruginosa (pyocyanic bacillus) to antiseptics and antibiotics. IX. Effect of culture media on the antiseptogram].
    Delmotte A; Beumer J
    Therapie; 1976; 31(2):257-65. PubMed ID: 821171
    [No Abstract]   [Full Text] [Related]  

  • 9. Susceptibility of "Pseudomonas aeruginosa" to combinations of antibiotics.
    Klastersky J; Beumer J; Daneau D
    Pathol Biol (Paris); 1972 Sep; 20(15):643-7. PubMed ID: 4342650
    [No Abstract]   [Full Text] [Related]  

  • 10. Colistin susceptibility testing: time for a review.
    Albur M; Noel A; Bowker K; Macgowan A
    J Antimicrob Chemother; 2014 May; 69(5):1432-4. PubMed ID: 24379306
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activity of combinations of antibacterial agents on Pseudomonas aeruginosa strains].
    Meitert E; Petrescu AM; Chiru M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(3):263-74. PubMed ID: 3097787
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of Pseudomonas aeruginosa sensitivity to antibiotics and features of interpreting the results].
    Givental' NI
    Antibiot Med Biotekhnol; 1987 Sep; 32(9):674-83. PubMed ID: 3124726
    [No Abstract]   [Full Text] [Related]  

  • 13. A rapid micromethod for the determination of the sensitivity to antibiotics of Pseudomonas aeruginosa.
    Rykner G; Scavizzi MR
    J Antimicrob Chemother; 1976 Jun; 2(2):217-9. PubMed ID: 821912
    [No Abstract]   [Full Text] [Related]  

  • 14. [Growth inhibition zones between polymyxin and sulphonamides].
    Breitfellner G
    Zentralbl Bakteriol Orig A; 1972 Aug; 221(3):357-66. PubMed ID: 4146475
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa.
    Pavillard ER; Miles H
    Clin Ther; 1980; 3(Spec Issue):134-8. PubMed ID: 6446387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pseudomonas aeruginosa strains: synergism and pyocinogenia induction].
    García-Quintana HG; Martińez MA
    Rev Med Chil; 1988 Nov; 116(11):1167-71. PubMed ID: 3151707
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudomonas aeruginosa ATCC 49189, a new quality control strain for testing P. aeruginosa susceptibility to the aminoglycosides.
    Lally RT; Woolfrey BF; Enright MA
    J Clin Microbiol; 1989 Nov; 27(11):2616-8. PubMed ID: 2509514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa.
    Zheng Z; Tharmalingam N; Liu Q; Jayamani E; Kim W; Fuchs BB; Zhang R; Vilcinskas A; Mylonakis E
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotic associations on acting Pseudomonas aeruginosa].
    Duval J; Mathieu-Saint-Laurent P; Soussy CL
    Pathol Biol (Paris); 1971; 19(11):637-48. PubMed ID: 4997792
    [No Abstract]   [Full Text] [Related]  

  • 20. Performance of a commercial microdilution minimal inhibitory concentration procedure for aminoglycoside susceptibility testing of Pseudomonas aeruginosa.
    Etowski DC; Beckwith DG
    Am J Clin Pathol; 1981 Jun; 75(6):830-3. PubMed ID: 6789668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.